INSULIN-LIKE GROWTH FACTOR II mRNA-BINDING PROTEIN 3: A NOVEL PROGNOSTIC BIOMARKER FOR ORAL SQUAMOUS CELL CARCINOMA

被引:40
作者
Li, Shengjin [1 ]
Cha, JeongDan [1 ]
Kim, Jin [1 ,2 ]
Kim, Ki-Yeol [1 ]
Kim, Hyung-Jun [1 ,3 ]
Nam, Woong [1 ,3 ]
Cha, In-Ho [1 ,3 ]
机构
[1] Yonsei Univ, Coll Dent, Oral Canc Res Inst, Seoul 120749, South Korea
[2] Yonsei Univ, Coll Dent, Dept Oral Pathol, Seoul 120749, South Korea
[3] Yonsei Univ, Coll Dent, Dept Oral & Maxillofacial Surg, Seoul 120749, South Korea
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2011年 / 33卷 / 03期
基金
新加坡国家研究基金会;
关键词
IMP3; oral squamous cell carcinoma; clinicopathologic factors; survival; prognostic factor; CANCER PREVENTION; IMP3; EXPRESSION; METASTASIS; EVOLUTION; SURVIVAL; INVASION; KI-67; KOC;
D O I
10.1002/hed.21457
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Oral squamous cell carcinoma (OSCC) is caused by multiple factors, including carcinogen exposure. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is highly expressed in various cancer cells but is rarely expressed in normal cells. We investigated whether IMP3 can be used as a prognostic biomarker for OSCC. Methods. We performed immunohistochemistry and Western blotting to examine IMP3 expression in human tissues. We also investigated correlations among IMP3 expression, clinicopathologic factors, and overall survival. Results. IMP3 was overexpressed in OSCC cells. The expression was correlated with high histologic grade, lymph node metastasis, and advanced tumor and clinical stages. Univariate analysis indicated that advanced clinical stages, lymph node metastases, and IMP3 expression were predictive factors for OSCC. Multivariate analysis showed that IMP3 expression was an independent prognostic indicator for OSCC. Conclusions. IMP3 expression was related to various clinicopathologic factors. IMP3 expression was an independent prognostic factor in patients with OSCC. (C) 2010 Wiley Periodicals, Inc. Head Neck 33: 368-374, 2011
引用
收藏
页码:368 / 374
页数:7
相关论文
共 24 条
  • [1] Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma
    Chuang, Hui-Ching
    Su, Chih-Ying
    Huang, Hsuang-Ying
    Huang, Chao-Cheng
    Chien, Chih-Yen
    Du, Yung-Ying
    Chuang, Jiin-Haur
    [J]. MODERN PATHOLOGY, 2008, 21 (12) : 1444 - 1450
  • [2] Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: Continuing research and implications for clinical practice
    Epstein, Joel B.
    Sciubba, James
    Silverman, Sol, Jr.
    Sroussi, Herve Y.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (10): : 948 - 958
  • [3] Green FL, 2002, AJCC CANC STAGING MA, P35
  • [4] External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma
    Hoffmann, Nathan E.
    Sheinin, Yuri
    Lohse, Christine M.
    Parker, Alexander S.
    Leibovich, Bradley C.
    Jiang, Zhong
    Kwon, Eugene D.
    [J]. CANCER, 2008, 112 (07) : 1471 - 1479
  • [5] RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma
    Jeng, Yung-Ming
    Chang, Cheng-Chi
    Hu, Fu-Chang
    Chou, Han-Yi E.
    Kao, Hsin-Lien
    Wang, Ting-Huang
    Hsu, Hey-Chi
    [J]. HEPATOLOGY, 2008, 48 (04) : 1118 - 1127
  • [6] Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study
    Jiang, Zhong
    Chu, Peigou G.
    Woda, Bruce A.
    Rock, Kenneth L.
    Liu, Qin
    Hsieh, Chung-Cheng
    Li, Cuizhen
    Chen, Wengang
    Duan, Hai Ou
    McDougal, Scott
    Wu, Chin-Lee
    [J]. LANCET ONCOLOGY, 2006, 7 (07) : 556 - 564
  • [7] Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells
    Lee, EJ
    Kim, J
    Lee, SA
    Kim, EJ
    Chun, YC
    Ryu, MH
    Yook, JI
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2005, 37 (05) : 379 - 390
  • [8] IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix:: an immunohistochemical study in comparison with p16INK4a expression
    Li, Cuizhen
    Rock, Kenneth L.
    Woda, Bruce A.
    Jiang, Zhong
    Fraire, Armando E.
    Dresser, Karen
    [J]. MODERN PATHOLOGY, 2007, 20 (02) : 242 - 247
  • [9] Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors
    Li, Lin
    Xu, Haodong
    Spaulding, Betsy O.
    Cheng, Liang
    Simon, Rochelle
    Yao, Jorge L.
    di Sant'Agnese, P. Anthony
    Bourne, Patricia A.
    Huang, Jiaoti
    [J]. HUMAN PATHOLOGY, 2008, 39 (08) : 1205 - 1211
  • [10] The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells
    Liao, BS
    Hu, Y
    Herrick, DJ
    Brewer, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (18) : 18517 - 18524